Skip to main content

Animations

MJFF Publications

3881 - 3890 of 6420 Results
Title
Year
  • Year
  • 2023
  • 2022
  • 2023
  • 2022
  • 2019
  • 2019
  • 2022
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Unconventional initiation of PINK1/Parkin mitophagy by Optineurin
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.04.021
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thickness
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2022.103300
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Neural correlates of impulse control behaviors in Parkinson’s disease: Analysis of multimodal imaging data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103315
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-019-0080-x
    Citation Count: 126
  • Summary Details
    OPEN
    Title: End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0217039
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognition
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
    Journal Name: Current Research in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.crneur.2022.100065
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Synergistic associations of depressive symptoms and aging on cognitive decline in early Parkinson’s disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100192
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100187
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.